Lignocaine vs Bupivacaine Infiltration for Postpartum Perineal Pain After Vaginal Delivery With E… (NCT06568289) | Clinical Trial Compass
RecruitingNot Applicable
Lignocaine vs Bupivacaine Infiltration for Postpartum Perineal Pain After Vaginal Delivery With Episiotomy in Primigravidae
Egypt60 participantsStarted 2024-03-01
Plain-language summary
In this study, we will compare the effect and safety of lignocaine versus bupivacaine infiltration for postpartum perineal pain after vaginal delivery with episiotomy in primigravidae.
Who can participate
Age range18 Years – 40 Years
SexFEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Primigravidae with the full term undergoing vaginal delivery with episiotomy.
* Pregnancies and singleton vertex cephalic fetuses.
* In the active phase of the first stage of labor.
Exclusion Criteria:
* Patients with history of drug allergies to study drugs as this will increase the risk of complications.
* Patients undergoing vaginal delivery under epidural or spinal anesthesia as they will affect post-operative pain and interfere with assessment of efficacy of local infiltration of the study drugs.
* Evidence of local infection at site of injection as this will interfere with the action of the study drug and will increase the risk of complications.
* Inability to cooperate as this will affect our assessment.
* Patient's refusal.
* Any intraoperative complications that will affect our outcome criteria (bleeding, organ injury) as they will affect patient's vital data and affect our assessment.
* Neurological comorbidities (chronic pain disorder, chronic systemic disease, neurological disorder, neuropathic pain) as they will need more analgesia.
* Drug abuse as they will be tolerant to the used analgesics.